These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3974685)

  • 1. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER; Cohanim M
    N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycollic aciduria).
    Watts RW; Veall N; Purkiss P; Mansell MA; Haywood EF
    Clin Sci (Lond); 1985 Jul; 69(1):87-90. PubMed ID: 4064559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients.
    Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS
    J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperoxaluria with normal alpha-ketoglutarate: glyoxylate carboligase activity. Treatment with isocarboxazid.
    Bourke E; Frindt G; Flynn P; Schreiner GE
    Ann Intern Med; 1972 Feb; 76(2):279-84. PubMed ID: 5009594
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
    Nguyen QV; Kälin A; Drouve U; Casez JP; Jaeger P
    Kidney Int; 2001 Jun; 59(6):2273-81. PubMed ID: 11380831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on some possible biochemical treatments of primary hyperoxaluria.
    Watts RW; Chalmers RA; Gibbs DA; Lawson AM; Purkiss P; Spellacy E
    Q J Med; 1979 Apr; 48(190):259-72. PubMed ID: 116301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes.
    Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
    J Urol; 1992 Sep; 148(3 Pt 2):986-9. PubMed ID: 1507356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of hyperoxaluria in generalized peroxisomal disorders.
    van Woerden CS; Groothoff JW; Wijburg FA; Duran M; Wanders RJ; Barth PG; Poll-The BT
    Mol Genet Metab; 2006 Aug; 88(4):346-50. PubMed ID: 16621644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model.
    Kaplon DM; Penniston KL; Darriet C; Crenshaw TD; Nakada SY
    J Endourol; 2010 Mar; 24(3):355-9. PubMed ID: 20078233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A; Ayiomamitis A; Grass L; Oreopoulos DG
    Int Urol Nephrol; 1988; 20(4):353-9. PubMed ID: 3170105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyproline ingestion and urinary oxalate and glycolate excretion.
    Knight J; Jiang J; Assimos DG; Holmes RP
    Kidney Int; 2006 Dec; 70(11):1929-34. PubMed ID: 17021603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity in residual alanine glyoxylate aminotransferase activity in hyperoxaluria type I: correlation with pyridoxine responsiveness.
    Wanders RJ; van Roermund CW; Jurriaans S; Schutgens RB; Tager JM; van den Bosch H; Wolff ED; Przyrembel H; Berger R; Schaaphok FG
    J Inherit Metab Dis; 1988; 11 Suppl 2():208-11. PubMed ID: 3141704
    [No Abstract]   [Full Text] [Related]  

  • 16. Mild metabolic hyperoxaluria and its response to pyridoxine.
    Gill HS; Rose GA
    Urol Int; 1986; 41(5):393-6. PubMed ID: 3811039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-carbon oxalogenesis compared in recurrent calcium oxalate stone formers and normal subjects.
    McWhinney BC; Nagel SL; Cowley DM; Brown JM; Chalmers AH
    Clin Chem; 1987 Jul; 33(7):1118-20. PubMed ID: 3594837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary oxalate and glycolate excretion in healthy infants and children.
    Leumann EP; Dietl A; Matasovic A
    Pediatr Nephrol; 1990 Sep; 4(5):493-7. PubMed ID: 2242313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
    Frishberg Y; Deschênes G; Groothoff JW; Hulton SA; Magen D; Harambat J; Van't Hoff WG; Lorch U; Milliner DS; Lieske JC; Haslett P; Garg PP; Vaishnaw AK; Talamudupula S; Lu J; Habtemariam BA; Erbe DV; McGregor TL; Cochat P;
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1025-1036. PubMed ID: 33985991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pyridoxine on sodium glycolate-induced hyperoxaluria in rats.
    Murthy MS; Talwar HS; Thind SK; Nath R
    Biochem Med; 1981 Aug; 26(1):77-84. PubMed ID: 7295305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.